Patients: Why NH-BMT?

National Leader in Blood and Marrow Transplants:

  • The ONLY BMT program in the country, and the ONLY BMT program in Georgia, to achieve survival outcomes that significantly exceed the expected survival rate for allogeneic transplants for the past 17 consecutive reporting cycles (2009-2025). **

  • Among the Best Allogeneic one year survival outcome data in the United States (www.nmdp.org), where the actual 2025 one-year survival rate is 78.9% *

  • Largest Allogeneic transplant program in Georgia

  • In the top percentage nationally for transplant volumes

The NH–BMT Program meets the criteria of an excellent transplant center.

  • The BMT physician team has completed post-hematology/oncology fellowship training in hematopoietic stem cell transplantation.

    1. Highly trained BMT/leukemia/immunotherapy team that includes a dedicated BMT health psychologist, social worker, clinical BMT PharmDs, nutritional services, physical therapy, and chaplain services.

    2. State-of-the-art facilities

    3. Comprehensive quality management program

    4. Among the BESTsurvival outcomes in United States

      • The ONLY BMT program in the country, and the only BMT program in Georgia, to achieve survival outcomes that significantly exceed the expected survival rate for allogeneic transplants for the past 17 consecutive reporting cycles (2009-2025). **

    5. BMTGA physicians coordinate pre- and post-transplant care with your referring physician. Be assured treatment recommendations will be the most current and state-of-the-art.

    6. Access to cutting-edge Clinical Trials

    7. NCI-NCORP: Northside Hospital Cancer Institute and Lewis Cancer and Research Pavilion have partnered with Georgia CORE to participate in NCORP. After a successful first five years, a statewide cancer research consortium has been awarded a six-year grant expected to result in more than $11 million in funding from the National Cancer Institute (NCI) to enroll even more Georgians in important clinical trials.

    8. The patient satisfaction survey for Northside Hospital’s inpatient BMT/Leukemia/Immunotherapy unit was in the 95th percentile, and they were likely to recommend it to friends and family. ***

* The American Society for Blood and Marrow Transplantation (ASBMT), The Foundation for Cellular Therapy (FACT) and the National Marrow Donor Program (NMDP) are three bone marrow transplant governing organizations that provide patients and family members with detailed information on how to identify an excellent transplant center: outstanding survival outcomes, experienced or trained staff, a comprehensive quality management program, and state-of-the-art facilities.
**For seventeen consecutive years (2009-2025), NH-BMT achieved survival outcomes that significantly exceeded the expected range, as reported in the Center for International Blood and Marrow Transplant Research's Final 2025 Transplant Center Specific Survival Report (page 35, center 151) and from reported outcome data from nmdp.org. There were 176 adult and pediatric transplant centers included in the analysis. This survival information includes only patients who received their first allogeneic transplant between January 1, 2021, and December 31, 2023, using unrelated or related donors, and who had reported follow-up. Specific transplant center information can be found at nmdp.org.
***2025 Press Ganey HCAHPS Regulatory Survey